Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine Safety and Efficacy in Kenyan Children and Infants
NCT02687373Phase 2Completed
- Sponsor
- Sanaria Inc.
- Start
- Jul 2016
- Primary completion
- Aug 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Sanaria PfSPZ Vaccine in malaria, sponsored by Sanaria Inc.. Started Jul 2016; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02687373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687373.